Acadia Healthcare Company, Inc. SEC filings document the company's behavioral healthcare operations, public-company governance and capital structure. Its disclosures describe subsidiaries that own, operate or manage acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, residential treatment centers and outpatient behavioral healthcare facilities in the U.S. and Puerto Rico.
Acadia's filings include Form 8-K reports on operating and financial results, Regulation FD materials, executive and director changes, separation and compensation arrangements, and shareholder voting outcomes. Proxy materials cover board elections, executive compensation, incentive compensation plans and annual-meeting proposals, while registered-security disclosures identify ACHC common stock on the NASDAQ Global Select Market.
Insider sale reported: Nasser Khan, listed as Chief Operating Officer and reporting person for Acadia Healthcare Company, Inc. (ACHC), disposed of 973 shares of common stock on 09/30/2025 at a reported price of $24.54 per share. After the transaction he beneficially owned 55,023 shares in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 10/01/2025.
Khrom-affiliated investors disclosed a meaningful 5.5% stake in Acadia Healthcare (ACHC), holding 5,037,448 shares directly through Khrom Investments and 5,044,376 shares when including Eric Khrom's direct holdings. The group acquired the shares in open-market purchases for an aggregate purchase price of approximately $132.89 million using working capital, and the shares are held in margin accounts. The filing states the investors believe ACHC is undervalued and that they have engaged, and intend to continue engaging, with the company’s management and board about strategic options to maximize shareholder value. The investors reserve the right to buy or sell additional securities, pursue derivative or hedging transactions, and potentially propose changes to operations, board composition, capital structure or other strategic actions.
Acadia Healthcare Company, Inc. is providing preliminary 2026 guidance and an interim operating update alongside a conference appearance. For 2026, the company expects total capital expenditures to decline by at least $300 million compared with its 2025 capital expenditure guidance of $600 to $650 million, indicating a materially lower investment spend next year. Acadia also expects to add 500 to 700 beds in 2026, including beds already under construction in 2025, highlighting ongoing capacity expansion.
For the third quarter of 2025, Acadia is disclosing a select interim operating metric, reporting same facility patient days growth to date of approximately 1.3%. The company notes that forward-looking statements, including these expectations, are subject to risks such as integration of expansions and acquisitions, changes in government and commercial reimbursement, the impact of the One Big Beautiful Bill Act on Medicaid financing and eligibility, labor and cost pressures, cybersecurity risks, and broader economic conditions.
Timothy Sides, Interim CFO of Acadia Healthcare (ACHC), reports direct beneficial ownership of 30,661 shares of common stock and ownership of stock options covering 4,825 underlying shares. The options include grants exercisable in 2022, 2023, and 2024 with exercise prices of $57.14, $53.40, and $80.87 and expirations in 2031, 2032, and 2033 respectively. Several equity awards have staggered vesting schedules that begin in 2026 and extend up to three years.
Wellington Management and related entities report beneficial ownership of 8,430,343 shares of Acadia Healthcare Company, Inc. common stock, representing approximately 9.15% of the class. The filing shows no sole voting or dispositive power; instead Wellington discloses shared voting power of 7,995,273 shares and shared dispositive power of 8,430,343 shares. The ownership is held of record by clients of Wellington’s investment advisers rather than by Wellington as a principal.
The filing identifies multiple Wellington entities as reporting persons, including entities classified as holding companies (HC) and investment advisers (IA). The filing also names the Vanguard Health Care Fund as an exception noted in the list of clients, without specifying a percentage for that fund.